Introduction of Tagraxofusp-erzs Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5 XW043Q5

ICD-10-PCS code XW043Q5 for Introduction of Tagraxofusp-erzs Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5 is a medical classification as listed by CMS under Anatomical Regions range.

Official Code Descriptor

Introduction of Tagraxofusp-erzs Antineoplastic into Central Vein, Percutaneous Approach, New Technology Group 5

Crosswalks

Tabs

No record found

Crosswalk an ICD-10-PCS code to CPT®

Additional/Related Information

Tabs
Section(X)Body System(W)Operation(0)Body Part(4)Approach(3)Device / Substance / Technology(Q)Qualifier(5)
New TechnologyAnatomical RegionsIntroductionCentral VeinPercutaneousTagraxofusp-erzs AntineoplasticNew Technology Group 5

No record found

Change TypeChange DatePrevious Descriptor
Code Added 10-01-2019
No need to flip from a code to the front of a book or to hunt through online PDFs to locate applicable chapter and block specific guidelines. See essential instructions from ICD-10-PCS Official Guidelines for Coding and Reporting right on your code details page.

Forum

Have a question about ICD-10-PCS XW043Q5 ? Start a discussion here